Jim Simons's position in Regeneron Pharmaceuticals is currently worth $131 Million. That's 0.20% of their equity portfolio (103rd largest holding). The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Jim Simons bought shares 23 more times and sold shares on 22 occasions. The investor's estimated purchase price is $173 Million, resulting in a loss of 24%.